Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01241162
Title Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications

neuroblastoma

osteosarcoma

synovial sarcoma

rhabdomyosarcoma

Ewing sarcoma

Therapies

Decitabine

Age Groups: child
Covered Countries USA


No variant requirements are available.